Search clinical trials for: Tolterodine

Total 99 results

Far Eastern Memorial Hospital

Recruiting

Comparisons of the Impact of Monotherapy With Mirabegron or Tolterodine Versus Combined Treatment With Mirabegron and Tolterodine on Autonomic Function and Bladder Blow Flow in Women With Overactive Bladder Syndrome: a Randomized Controlled Study

Female Patients With Overactive Bladder Syndrome

Taiwan
University of California, San Francisco
National Institute on Aging (NIA)

Recruiting

TReating Incontinence for Underlying Mental and Physical Health (TRIUMPH)

Overactive Bladder | Urinary Incontinence | Urinary Incontinence, Urge | Incontinence | Incontinence, Urinary | Incontinence, Urge

United States
China Medical University Hospital

Recruiting

Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive Bladder

Sjogren's Syndrome | Overactive Bladder Syndrome

Taiwan
Xuanwu Hospital, Beijing

Not yet recruiting

Efficacy Comparison Between Different Management Strategies for Consistent OAB in Patients With SVMs After Surgery

Overactive Bladder | Spinal Vascular Disorder Nos
Antonios Likourezos

Terminated

Omega-3 Fatty Acids as an Adjunctive Therapy for Stimulants in Children With ADHD

Attention Deficit Hyperactivity Disorder

United States
Brigham and Women's Hospital
Medical University of Silesia

Completed

Inflammation in Women With Urgency Urinary Incontinence Treated With Anticholinergics

Urinary Incontinence | Urgency Urinary

United States
Kasr El Aini Hospital

Completed

Low Dose Tadalafil for Treatment of Female OAB Syndrome: Short Term Follow up.

Female Patients With Overactive Bladder Syndrome or Female Patients With Urgency or Urgency Urinary Incontinence

Egypt
Cleveland Clinic Florida
Astellas Pharma US, Inc.

Terminated

Over Active Bladder Patients Having Sling Surgery

Overactive Bladder

United States
Sanofi

Completed

A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes Mellitus

Type1 Diabetes Mellitus

Germany
Yuzuncu Yıl University

Completed

Tolterodine Relieves Overactive Bladder Symptoms in Women With Moderate-to-severe Obstructive Sleep Apnea Syndrome

Overactive Bladder | Obstructive Sleep Apnea | Overactive Bladder Syndrome

Turkey
Urovant Sciences GmbH

Completed

An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB). (Empowur)

Overactive Bladder

United States
Urovant Sciences GmbH

Completed

A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) (Empowur)

Overactive Bladder

United States, Latvia, Hungary, Canada, Lithuania, Poland
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Tolterodine Drug Use Investigation.(Post Marketing Commitment Plan) (POTTOR)

Overactive Bladder
Pfizer's Upjohn has merged with Mylan to form Viatris...

Terminated

Web-based Methodology Trial to Evaluate the Efficacy and Safety of Tolterodine ER in Subjects With Overactive Bladder (REMOTE)

Overactive Bladder

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study to Measure the Effect of Tolterodine Extended Release on the Thickness of the Bladder Wall in Patients With Overactive Bladder

Urinary Incontinence

United Kingdom
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women

Urinary Incontinence

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Effects Of Detrol LA On Memory And Cognition In Elderly Population

Cognition | Memory

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Effect Of Detrol LA With Behavioral Intervention In Overactive Bladder Subjects Dissatisfied With Recent OAB Medication.

Urinary Incontinence

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction

Urinary Incontinence

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet

Urinary Incontinence

China
Pfizer's Upjohn has merged with Mylan to form Viatris...
Pfizer

Completed

Study to Determine The Effectiveness Of Detrusitol In Patients Diagnosed With OAB

Urinary Incontinence
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Pharmacokinetics and Relative Bioavailability Study

Urinary Bladder, Overactive

Singapore
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study to Evaluate the Efficacy of Tolterodine on Specific Symptoms in Adult Patients With Overactive Bladder.

Urinary Bladder, Overactive

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Detrol LA In Men With Overactive Bladder.

Overactive Bladder (OAB)

United States, Canada, Germany, Korea, Republic of, Spain, Turkey, Taiwan, Italy, Slovakia, Denmark, South Africa, United Kingdom, Mexico, Sweden, Norway
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Evaluation of the Link Between Bladder Sensation and Changes in Skin Electrical Conductance and Heart Rate.

Overactive Bladder

Switzerland
Ottawa Hospital Research Institute

Completed

4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases (REaCT-BTA)

Breast Cancer | Prostate Cancer | Metastasis

Canada
Astellas Pharma Singapore Pte. Ltd.

Completed

A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China

Overactive Bladder (OAB)

Korea, Republic of, Taiwan
Astellas Pharma Global Development, Inc.

Completed

A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB) (PREFER)

Overactive Bladder (OAB)

United States, Canada
Samsung Medical Center

Completed

Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)

Overactive Bladder | Benign Prostatic Hyperplasia

Korea, Republic of
KYU-SUNG LEE
Pfizer

Completed

Exploring Predictors of Symptoms Relapse After Discontinuation of Treatment in Overactive Bladder (OAB) Patients

Overactive Bladder

Korea, Republic of
Astellas Pharma Singapore Pte. Ltd.

Completed

Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia Oceania

Overactive Bladder (OAB)

Korea, Republic of, Australia
University of Wisconsin, Madison

Completed

Treatment of Symptoms After Stent Placement for Urinary Tract Obstruction

Ureteral Obstruction

United States
R-Pharm
Synergy Research Inc.

Completed

Efficacy and Safety Evaluating Study to Compare Uritos® (Imidafenacin) and Urotol® (Tolterodine) for Treatment of Overactive Bladder.

Overactive Bladder

Russian Federation
University of New Mexico
National Center for Complementary and Integrative Health (NCCIH)

Completed

Brain-Centered Therapy Versus Medication for Urgency Urinary Incontinence : Hypnotherapy Or Pharmacotherapy (Hyp-hOP)

Urinary Incontinence, Urge

United States
University of California, San Francisco

Completed

Treatment of Incontinence Without Memory Problems (TRIUMPH)

Urge Incontinence | Urinary Incontinence, Urge

United States
Merck Sharp & Dohme LLC

Completed

A Study of the Efficacy and Safety of Vibegron (MK-4618) in Participants With Overactive Bladder (OAB) (MK-4618-008)

Urinary Bladder, Overactive
University Hospital Inselspital, Berne
University of Washington; Ludwig-Maximilians - University of Munich; Aalborg...

Completed

Genetic Determinants of Amitriptyline Efficiency for Pain Treatment - Part II

Chronic Pain

Switzerland
University Hospital Inselspital, Berne
University of Washington; Ludwig-Maximilians - University of Munich; Aalborg...

Completed

Genetic Determinants of Amitriptyline Efficiency for Pain Treatment

Chronic Pain

Switzerland
Astellas Pharma Inc

Completed

Postmarketing Study to Evaluate add-on Therapy With Anticholinergics in Patients With Overactive Bladder (OAB) on Mirabegron.

Overactive Bladder (OAB)

Japan
Far Eastern Memorial Hospital
National Science Council, Taiwan

Completed

Bladder Wall Blood Perfusion Pattern and Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms, and the Association of That Perfusion Pattern and Therapeutic Efficacy of Antimuscarincs for Female Overactive Bladder Syndrome.

Lower Urinary Tract Symptoms

Taiwan
Merck Sharp & Dohme LLC

Terminated

A Study of the Pharmacokinetics and Pharmacodynamics of Vibegron (MK-4618) in Women With Overactive Bladder (MK-4618-004)

Overactive Bladder | Overactive Urinary Bladder
Pfizer

Completed

A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.

Urinary Bladder, Overactive

Canada, United States, Germany, Russian Federation, Czechia, Egypt, Bulgaria, Finland, Hungary, Korea, Republic of, Mexico, Poland, South Africa, Sweden, Ukraine
University of Alabama at Birmingham
Pfizer

Completed

Detrol Long Acting (LA) vs Estrace Vaginal Cream for the Treatment of Overactive Bladder Symptoms (DRIVE)

Overactive Bladder
Ferring Pharmaceuticals

Completed

Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women

Overactive Bladder

United States
Brigham and Women's Hospital
Pfizer

Terminated

A Comparison of Tolterodine and Placebo Treatments on Nocturnal Frequency and Sleep Quality in Women After Menopause.

Urinary Incontinence

United States
Merck Sharp & Dohme LLC

Completed

A Study to Test the Effects of Tolterodine Tartrate in Patients With Overactive Bladder (0000-107)

Overactive Bladder
Mansoura University

Completed

Effect of Long Acting Anticholinergic on Nocturnal Incontinence After Radical Cystectomy and Orthotopic Neobladder

Nocturnal Incontinence
Astellas Pharma Inc

Completed

Study to Assess the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder (SCORPIO)

Urinary Bladder, Overactive

Australia, Belgium, France, Spain, Sweden, Bulgaria, Romania, Italy, Greece, South Africa, Austria, Poland, United Kingdom, Hungary, Denmark, Netherlands, Switzerland, Ireland, Lithuania, Russian Federation, Germany, Latvia, Slovakia, Finlan... and more
Astellas Pharma Inc

Completed

Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder (TAURUS)

Urinary Bladder, Overactive

Canada, Poland, Belgium, Spain, Sweden, United States, Romania, Italy, France, Austria, United Kingdom, Germany, Hungary, Australia, Denmark, Netherlands, Switzerland, Lithuania, Russian Federation, Latvia, South Africa, Slovakia, F... and more
Shanghai Institute of Acupuncture, Moxibustion...
RenJi Hospital

Completed

Comparison of Electrical Pudendal Nerve Stimulation and Tolterodine Tartrate for Urgency-Frequency Syndrome in Women

Urgency-frequency Syndrome

China

Search clinical trials for: Tolterodine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahamas

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations